Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hajer Alasfour"'
Publikováno v:
JGH Open, Vol 6, Iss 4, Pp 241-250 (2022)
Abstract Background and Aim The use of biologics and small molecules has been a concern for patients with inflammatory bowel disease (IBD) during the COVID‐19 pandemic. We aimed to assess the association between the risk of COVID‐19‐related hos
Externí odkaz:
https://doaj.org/article/16fca20c785c489d9841e0f36c325551
Autor:
Mohammad Shehab, Hajer Alasfour, Israa Abdullah, Ghadeer Alhendi, Anwar Alhadab, Ahmad Alfadhli, Ali H. Ziyab, Robert Battat
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Anti-drug antibodies to infliximab (ATI) and adalimumab (ATA) are associated with loss of response to tumor necrosis factor antagonist (anti-TNF) therapy in inflammatory bowel disease (IBD). We evaluated the relationship between patient s
Externí odkaz:
https://doaj.org/article/300c06f5d5f84525bcb42be3645dc684
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Tumor necrosis factor antagonists (anti-TNF) therapies are used for the management of moderate to severe inflammatory bowel disease (IBD). Anti-TNF combination therapy, with immunomodulators, has been shown to reduce immunogenicity, esp
Externí odkaz:
https://doaj.org/article/ebd1946763674fa1946649d09b20c5a0
Publikováno v:
JGH open : an open access journal of gastroenterology and hepatology. 6(4)
The use of biologics and small molecules has been a concern for patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic. We aimed to assess the association between the risk of COVID-19-related hospitalization and these agents.We m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ac96aa46703760f9999261de88e322
https://pubmed.ncbi.nlm.nih.gov/35475207
https://pubmed.ncbi.nlm.nih.gov/35475207
BackgroundThe use of biological therapies and small molecules have been a concern for patients with inflammatory bowel disease (IBD) during COVID-19 pandemic. We aim to assess the association between risk of COVID-19 related hospitalization and these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89760e0dc5e7dc726ae5df6f86b0fb2c
https://doi.org/10.1101/2021.10.24.21265344
https://doi.org/10.1101/2021.10.24.21265344
